title: [Current therapy of Sneddon's syndrome].
authors.affiliation: Universitätsklinik und Poliklinik für Dermatologie und Venerologie, Martin-Luther-Universität Halle-Wittenberg, Halle, Saale. johannes.wohlrab@medizin.uni-halle.de
authors.forename: J
authors.initials: J
authors.lastname: Wohlrab
authors.forename: M
authors.initials: M
authors.lastname: Fischer
authors.forename: W C
authors.initials: WC
authors.lastname: Marsch
mesh_terms: D000527:Alprostadil / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001775:Blood Circulation / Q000187:drug effects; D002216:Captopril / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011379:Prognosis; D012307:Risk Factors; D012907:Smoking; D018860:Sneddon Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D013988:Ticlopidine / Q000627:therapeutic use
chemical_list: D000959:Antihypertensive Agents; D005343:Fibrinolytic Agents; D002216:Captopril; D000527:Alprostadil; D013988:Ticlopidine